# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001636282-25-000102
Filing Date
2025-11-04
Accepted
2025-11-04 16:01:37
Documents
70
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | syre-20250930.htm iXBRL | 10-Q | 1764983
2 | EX-31.1 | spyre-20250930xex311.htm | EX-31.1 | 9604
3 | EX-31.2 | spyre-20250930xex312.htm | EX-31.2 | 9613
4 | EX-32.1 | spyre-20250930xex321.htm | EX-32.1 | 6327
10 |  | syre-20250930_g1.jpg | GRAPHIC | 96553
| Complete submission text file | 0001636282-25-000102.txt |  | 8492538

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | syre-20250930.xsd | EX-101.SCH | 54946
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | syre-20250930_cal.xml | EX-101.CAL | 57797
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | syre-20250930_def.xml | EX-101.DEF | 361002
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | syre-20250930_lab.xml | EX-101.LAB | 656008
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | syre-20250930_pre.xml | EX-101.PRE | 510827
73 | EXTRACTED XBRL INSTANCE DOCUMENT | syre-20250930_htm.xml | XML | 1166046

Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37722 | Film No.: 251448813
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)